首页> 外国专利> COMPOSITION OF N-3 FATTY ACIDS HAVING HIGH CONCENTRATION OF EPA AND/OR DHA AND CONTAINING N-6 FATTY ACIDS

COMPOSITION OF N-3 FATTY ACIDS HAVING HIGH CONCENTRATION OF EPA AND/OR DHA AND CONTAINING N-6 FATTY ACIDS

机译:具有高浓度EPA和/或DHA且包含N-6脂肪酸的N-3脂肪酸的组成

摘要

A composition of long-chain polyunsaturated fatty acids containing at least 80% by weight of eicosapentaenoic acid (EPA, C20:5 n-3) and/or docosahexaenoic acid (DHA, C22:6 n-3) and at least 3% by weight of n-6 fatty acids, particularly C20:4 n-6 and C22:5 n-6, is reported. For a better chemical and biological characterization of the composition, the content of other C20, C21 and C22 n-3 acids different from EPA and DHA is preferably reduced to less than 3% by weight. In the composition all said acids are present in the form of free acids, or their salts, or C1-C3 alkyl esters. The described composition is useful for the production of a dietetic or pharmaceutical preparation useful for treatment of conditions sensitive to the action of EPA and DHA, particularly in subjects potentially exposed to bleeding problems or to problems caused by coagulation defects.
机译:长链多不饱和脂肪酸的组合物,其包含按重量计至少80%的二十碳五烯酸(EPA,C20:5 n-3)和/或二十二碳六烯酸(DHA,C22:6 n-3)和按重量计至少3%报告了n-6脂肪酸的重量,特别是C20:4 n-6和C22:5 n-6。为了更好地对该组合物进行化学和生物学表征,优选将不同于EPA和DHA的其他C 20,C 21和C 22 n-3酸的含量降低至小于3重量%。在组合物中,所有所述酸均以游离酸或其盐或C 1 -C 3烷基酯的形式存在。所述组合物可用于制备饮食或药物制剂,所述饮食或药物制剂可用于治疗对EPA和DHA的作用敏感的病症,特别是在可能暴露于出血问题或由凝血缺陷引起的问题的受试者中。

著录项

  • 公开/公告号US2010160435A1

    专利类型

  • 公开/公告日2010-06-24

    原文格式PDF

  • 申请/专利权人 TIBERIO BRUZZESE;

    申请/专利号US20060063321

  • 发明设计人 TIBERIO BRUZZESE;

    申请日2006-08-08

  • 分类号A61K31/20;

  • 国家 US

  • 入库时间 2022-08-21 18:54:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号